Jubilant gets USFDA nod for generic levofloxacin tablets
The company has received approval from the US Food and Drug Administration (USFDA) to market generic version of Levaquin tablets in strengths of 250 mg and 500 mg in the American market, the firm said in a statement.
Jun 23, 2015, 15:39 PM ISTJubilant Life shares gain over 2% at close
Trimming most of its initial gains on profit-booking, shares of Jubilant Life Sciences ended over 2 percent higher on Wednesday.
Jun 17, 2015, 17:39 PM IST